Related Experiment Videos
Complement and Fc-receptors in regulation of the antibody response
1Department of Pathology, Uppsala University, Sweden. Birgitta.Heyman@patologi.uu.se
Immunology Letters
|December 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
The American journal of gastroenterology·2017
Antigen conjugated to anti-CD23 antibodies is rapidly transported to splenic follicles by recirculating B cells.
Scandinavian journal of immunology·2014
[Genital lymphedema associated with Crohn's disease].
La Revue de medecine interne·2014
Complications of intestinal stomas.
The British journal of surgery·2010
Expression and clinical characteristics of CD161 in primary biliary cholangitis.
Immunology letters·2026
Innate Lymphoid Cells and diet: the multitask cells in metabolic syndrome progression.
Immunology letters·2026
Beyond the M-spike - immunoparesis and multiple myeloma. A narrative review.
Immunology letters·2026
Killing to cure: harnessing poxvirus-driven cell death for viral immunotherapy.
Immunology letters·2026
Unfractionated Heparin and Low-Molecular-Weight Heparin in Sepsis: Anti-Inflammatory and Anticoagulant Effects Versus No Anticoagulation-A Propensity Score-Matched Analysis.
Journal of clinical laboratory analysis·2026
The ubiquitin system in normal and infected germinal center B cells.
FEBS letters·2026
Gut Microbiota Mediates the Relationship Between Immune Cells and Familial Hypercholesterolemia: A Mendelian Randomization Study.
Endocrine, metabolic & immune disorders drug targets·2026
Tumor-responsive nanoparticles precisely overcome hypoxia-mediated STING dysfunction to unleash potent antitumor immunity.
Acta pharmaceutica Sinica. B·2026
Self-assembled supramolecular nanoparticles of α-mangostin for targeted STING activation and enhanced tumor immunotherapy.
Acta pharmaceutica Sinica. B·2026